Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses

被引:9
|
作者
Macho-Fernandez, Elodie [1 ,2 ,3 ,4 ,5 ]
Chekkat, Neila [6 ]
Ehret, Christophe [6 ]
Thomann, Jean-Sebastien [6 ]
De Giorgi, Marcella [6 ]
Spanedda, Maria Vittoria [6 ]
Bourel-Bonnet, Line [6 ]
Betbeder, Didier [7 ,8 ]
Heurtault, Beatrice [6 ]
Faveeuw, Christelle [1 ,2 ,3 ,4 ,5 ]
Fournel, Sylvie [6 ]
Frisch, Benoit [6 ]
Trottein, Francois [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Lille, CIIL, U1019, UMR 8204, F-59000 Lille, France
[2] CNRS, UMR 8204, F-59000 Lille, France
[3] INSERM, U1019, F-59000 Lille, France
[4] CHU Lille, F-59000 Lille, France
[5] Inst Pasteur, F-59000 Lille, France
[6] Univ Strasbourg, CNRS, CAMB UMR 7199, F-67000 Strasbourg, France
[7] Univ Lille 2, CHRU Lille, INSERM, LIRIC,UMR 995, F-59045 Lille, France
[8] Univ Artois, F-62000 Arras, France
关键词
iNKT; alpha-GalCer formulations; Liposomes; Micelles; Water-soluble alpha-GalCer; Cancer; V-ALPHA-24-INVARIANT NKT CELLS; LUNG-CANCER PATIENTS; DENDRITIC CELLS; ANTIGEN PRESENTATION; VACCINE ADJUVANTS; PHASE-I; IMMUNITY; DELIVERY; INNATE; LIPOSOMES;
D O I
10.1016/j.ijpharm.2017.07.054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potent antitumor effect of alpha-galactosylceramide (alpha-GalCer) is based on its recognition by invariant Natural Killer T cells (iNKT) after its capture and presentation by antigen presenting cells including dendritic cells (DCs). Synthetic alpha-GalCer has already been tested in advanced cancer patients but no or only moderate clinical responses were obtained. To optimize alpha-GalCer efficacy, we have postulated that alternative formulations impacting its molecular organization in aqueous medium could modify DC uptake and iNKT-based immune responses. To this end, we have developed two strategies: (1) the formulation of alpha-GalCer in non-cationic liposomes and (2) the synthesis of a water-soluble alpha-GalCer analogue by anchoring a polyethyleneglycol moiety on its sugar head. The biological activities of these new preparations were compared to that induced by the classically used Polysorbate 20 alpha-GalCer micelles. Both formulations retained their uptake by DCs and activated iNKT cells both in vitro and in vivo. Despite a lower cytokine production, the formulations induced a potent immune response able to control lung murine carcinoma. In conclusion, it is possible to increase alpha-GalCer solubility in aqueous solution without limiting its antitumor properties. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:354 / 363
页数:10
相关论文
共 50 条
  • [41] Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
    Long, Eric O.
    Kim, Hun Sik
    Liu, Dongfang
    Peterson, Mary E.
    Rajagopalan, Sumati
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 31, 2013, 31 : 227 - 258
  • [42] Activation and function of natural killer cell responses during viral infections
    Biron, CA
    CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) : 24 - 34
  • [43] Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection
    Scott, MJ
    Hoth, JJ
    Turina, M
    Woods, DR
    Cheadle, WG
    CYTOKINE, 2006, 33 (02) : 79 - 86
  • [44] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Yoshikuni
    Ishimori, Naoki
    Saito, Akimichi
    Kinugawa, Shintaro
    Yokota, Takashi
    Takada, Shingo
    Nakano, Ippei
    Kakutani, Naoya
    Yamanashi, Katsuma
    Anzai, Toshihisa
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 27 (19) : 2358 - 2361
  • [45] Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates doxorubicin-induced cardiotoxicity in mice
    Obata, Y.
    Ishimori, N.
    Saito, A.
    Kinugawa, S.
    Nakano, I.
    Kakutani, N.
    Yamanashi, K.
    Anzai, T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 925 - 925
  • [46] α-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation
    Matsuda, H
    Suda, T
    Sato, J
    Nagata, T
    Koide, Y
    Chida, K
    Nakamura, H
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (01) : 22 - 31
  • [47] Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice
    Akao, Yuusuke
    Ebihara, Takashi
    Masuda, Hisayo
    Saeki, Yoshiko
    Akazawa, Takashi
    Hazeki, Kaoru
    Hazeki, Osamu
    Matsumoto, Misako
    Seya, Tsukasa
    CANCER SCIENCE, 2009, 100 (08): : 1494 - 1501
  • [48] Natural killer T cell ligand α-galactosylceramide inhibited lymph node metastasis of highly metastatic melanoma cells
    Nakui, M
    Iwakabe, K
    Ohta, A
    Sekimoto, M
    Sato, M
    Makuuchi, H
    Kawano, T
    Taniguchi, M
    Nishimura, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (08): : 801 - 804
  • [49] Application of natural killer T cells in antitumor immunotherapy
    Hong, Changwan
    Park, Se-Ho
    CRITICAL REVIEWS IN IMMUNOLOGY, 2007, 27 (06) : 511 - 525
  • [50] Immunotherapeutic strategies targeting natural killer T cell responses in cancer
    Susannah C. Shissler
    Dominique R. Bollino
    Irina V. Tiper
    Joshua P. Bates
    Roshanak Derakhshandeh
    Tonya J. Webb
    Immunogenetics, 2016, 68 : 623 - 638